🟢 Anixa Biosciences is trading 10.37% up in pre-market on September 2, 2026; no clear catalyst identified

Anixa Biosciences is trading 10.37% up in pre-market at $3.62, with no clear company-specific catalyst identified.

• The stock closed at $3.28 on September 1, 2026.
• Searches found no new company-specific announcement, earnings release, or filing explaining the rise; the latest identified news concerns upcoming September healthcare-conference presentations that predate the move and do not clearly explain it.
• Broader U.S. futures are lower, so market sentiment does not appear to account for the gain.